Showing results (471-480 of 500) with videos related to
Sort By:
Pageof 50
Science Translational Medicine|November 9, 2022
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapiesDaniel B Goodman, Camillia S Azimi, Kendall Kearns, et al.Diabetologia|April 8, 2016
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trialStephen E Gitelman, Peter A Gottlieb, Eric I Felner, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trialStephen E Gitelman, Peter A Gottlieb, Mark R Rigby, et al.Science Translational Medicine|November 27, 2015
Type 1 diabetes immunotherapy using polyclonal regulatory T cellsJeffrey A Bluestone, Jane H Buckner, Mark Fitch, et al.Diabetes|June 23, 2012
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell functionS Alice Long, Mary Rieck, Srinath Sanda, et al.Science (New York, N.Y.)|March 3, 2018
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexesJonathan T Sockolosky, Eleonora Trotta, Giulia Parisi, et al.Cell|April 18, 2020
Pooled Knockin Targeting for Genome Engineering of Cellular ImmunotherapiesTheodore L Roth, P Jonathan Li, Franziska Blaeschke, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2015
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226Christopher A Fuhrman, Wen-I Yeh, Howard R Seay, et al.Cell Reports|May 10, 2012
A resource for the conditional ablation of microRNAs in the mouseChong Yon Park, Lukas T Jeker, Karen Carver-Moore, et al.The Lancet. Diabetes & Endocrinology|July 2, 2021
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen E Gitelman, Brian N Bundy, Ele Ferrannini, et al.Pageof 50